Live feed06:05:32·646dINSIDERFilingvia QuantisnowVP Clinical Reg Affairs Thompson Jaye bought $11,080 worth of shares (800 units at $13.85), increasing direct ownership by 0.30% to 263,148 units (SEC Form 4)ByQuantisnow·Wall Street's wire, on your screen.GLSI· Greenwich LifeSciences Inc.Health CareOriginal source
